Background: This retrospective study is designed to evaluate factors affecting survival in a population of patients receiving pulmonary metastasectomy after gynecologic cancers. Methods: Nineteen patients with isolated lung metastases (one or two) were surgically treated with R0 resection. Four of them underwent lobectomies. Results: Six patients (31.6%) received adjuvant therapy and 11 (58%) experienced recurrences after metastasectomy. Five-and ten-year survival were 40.9% and 31.4%, respectively. Five-year survival in patients receiving adjuvant therapy was 52.4%. At multivariate analysis factors negatively influencing survival were a disease-free interval (DFI) of less than 24 months and recurrence after pulmonary metastasectomy. Conclusions: Pulmonary resection for metastatic gynecologic cancer is feasible and effective; adequate selection of patients is mandatory to achieve satisfactory results and long-term survival.
Pulmonary metastasectomy in uterine malignancies. Outcome and prognostic factors / Anile, Marco; Mantovani, Sara; Pecoraro, Ylenia; Carillo, Carolina; Gherzi, Lorenzo; Pagini, Andreina; Rendina, Erino Angelo; Venuta, Federico; Diso, Daniele. - In: JOURNAL OF THORACIC DISEASE. - ISSN 2072-1439. - STAMPA. - 9:Suppl 12(2017), pp. S1273-S1277. [10.21037/jtd.2017.07.46]
Pulmonary metastasectomy in uterine malignancies. Outcome and prognostic factors
Anile, Marco
;Mantovani, Sara;Pecoraro, Ylenia;Carillo, Carolina;Gherzi, Lorenzo;Pagini, Andreina;Rendina, Erino Angelo;Venuta, Federico;Diso, Daniele
2017
Abstract
Background: This retrospective study is designed to evaluate factors affecting survival in a population of patients receiving pulmonary metastasectomy after gynecologic cancers. Methods: Nineteen patients with isolated lung metastases (one or two) were surgically treated with R0 resection. Four of them underwent lobectomies. Results: Six patients (31.6%) received adjuvant therapy and 11 (58%) experienced recurrences after metastasectomy. Five-and ten-year survival were 40.9% and 31.4%, respectively. Five-year survival in patients receiving adjuvant therapy was 52.4%. At multivariate analysis factors negatively influencing survival were a disease-free interval (DFI) of less than 24 months and recurrence after pulmonary metastasectomy. Conclusions: Pulmonary resection for metastatic gynecologic cancer is feasible and effective; adequate selection of patients is mandatory to achieve satisfactory results and long-term survival.File | Dimensione | Formato | |
---|---|---|---|
Anile_Pulmonary-metastasectomy-uterine_2017.pdf
accesso aperto
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Creative commons
Dimensione
142.39 kB
Formato
Adobe PDF
|
142.39 kB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.